Core Viewpoint - COEPTIS, Inc. has announced a strategic partnership with NUBURU, Inc. to enhance operational efficiency and revamp business models in the defense-tech and security sectors through advanced technology and AI integration [1][3][4]. Company Overview - COEPTIS, Inc. is a biopharmaceutical and technology company focused on innovative cell therapy platforms for various diseases, aiming to improve patient outcomes through advanced research and development [6][7]. - NUBURU, Inc. specializes in high-power blue laser technology and is executing a comprehensive growth strategy to expand into defense-tech and operational resilience solutions [10]. Partnership Details - The partnership involves COEPTIS' NexGenAI Affiliates Network assisting NUBURU in its Transformation Plan using AI-driven capabilities and robotic process automation [2][5]. - This collaboration is expected to enhance NUBURU's marketing and B2B sales processes, particularly in the defense and security sectors, leveraging its expertise in laser technology [3][4]. Strategic Goals - The integration of NexGen's AI capabilities is aimed at optimizing marketing strategies, enhancing customer engagement, and implementing operational efficiencies for NUBURU [5][6]. - NUBURU's Executive Chairman emphasized that this partnership aligns with their vision of creating synergies across acquisitions and enhancing market presence in high-value sectors [4][10].
COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan